Yahia Tanani-El

Truro, ENG TR13LJ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

In Vitro Antitumor Properties of Simvastatin-Loaded SBA-16 Mesoporous Nanoparticles Using Two- and Three-Dimensional Colorectal Spheroid Models.

In Vitro Antitumor Properties of Simvastatin-Loaded SBA-16 Mesoporous Nanoparticles Using Two- and Three-Dimensional Colorectal Spheroid Models.

Journal: Pharmaceutics
Published: May 25, 2026

Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.

Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 20, 2026

Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation.

Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation.

Journal: Pharmaceutics
Published: May 15, 2026

Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology.

Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology.

Journal: Biology
Published: April 20, 2026

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026

Harnessing Machine Learning for Accelerated Drug Discovery: Opportunities and Unmet Challenges.

Harnessing Machine Learning for Accelerated Drug Discovery: Opportunities and Unmet Challenges.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 23, 2026

Ambient-Stable mRNA Medicines: Emerging Paradigms in Dry and Solid-State Formulation.

Ambient-Stable mRNA Medicines: Emerging Paradigms in Dry and Solid-State Formulation.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 29, 2026

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials.

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials.

Journal: Frontiers in pharmacology
Published: December 10, 2025

Natural killer cell therapies in cancer: innovations, challenges, and future directions.

Natural killer cell therapies in cancer: innovations, challenges, and future directions.

Journal: Expert opinion on biological therapy
Published: December 06, 2025

Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management.

Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management.

Journal: Biology
Published: December 03, 2025

Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.

Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.

Journal: PloS one
Published: October 22, 2025

Correction: El-Tanani et al. Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine. Pharmaceutics 2025, 17, 375.

Correction: El-Tanani et al. Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine. Pharmaceutics 2025, 17, 375.

Journal: Pharmaceutics
Published: August 27, 2025
Showing 1-12 of 36

Last Updated: 09/26/2026